Evidence map›Paper›PMID 35052939›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study.

Christopher Kiss, Declan Connoley, Kathryn Connelly, Kylie Horne, Tony Korman, Ian Woolley, Jillian S Y Lau

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Dietary prevention of antibiotic-induced dysbiosis and mortality upon aging in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  5. Infections in Patients with Mechanical Circulatory Support.Infectious disease clinics of North America · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher KissMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.
Declan ConnoleyMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.ORCID 0000-0003-1440-1756
Kathryn ConnellyMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.
Kylie HorneMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.
Tony KormanMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.ORCID 0000-0002-6155-8353
Ian WoolleyMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.ORCID 0000-0003-2928-1291
Jillian S Y LauMonash Infectious Diseases, Monash Medical Centre, Monash Health, Clayton, VIC 3168, Australia.ORCID 0000-0002-6797-4307
Monash Medical Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about the impacts at an individual level of long-term antibiotic consumption. We explored health outcomes of long-term antibiotic therapy prescribed to a cohort of patients to suppress infections deemed incurable.

methodsWe conducted a 5-year longitudinal study of patients on long-term antibiotics at Monash Health, a metropolitan tertiary-level hospital network in Australia. Adults prescribed antibiotics for >12 months to suppress chronic infection or prevent recurrent infection were included. A retrospective review of medical records and a descriptive analysis was conducted.

resultsTwenty-seven patients were followed up during the study period, from 29 patients originally identified in Monash Health in 2014. Seven of the 27 patients (26%) died from causes unrelated to the suppressed infection, six (22%) ceased long-term antibiotic therapy and two (7%) required treatment modification. Fifteen (56%) were colonised with multiresistant microorganisms, including vancomycin resistant Enterococci, methicillin resistant

conclusionsThis work highlights the potential pitfalls of long-term antibiotic therapy, and the frailty of this cohort, who are often ineligible for definitive curative therapy.

Indexed as

antibioticsantimicrobial resistancelife-longmulti-resistant organismssuppression

Identifiers

PMID35052939
PMCPMC8772790
OpenAlexW4206677831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.